Abiopharma

Clinical trial NCT07614776 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-05-27 3. completion date: 2028-01-17 → 2028-01-12 4. primary completion date: 2027-08-03 → 2027-07-31

Clinical trial NCT03941314 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2026-03-01 → 2026-03-19 3. primary completion date: 2026-03-01 → 2026-03-19

Clinical trial NCT07195708 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-30 → 2026-06-03

Clinical trial NCT05549921 updates: 1. status: UNKNOWN → TERMINATED 2. completion date: 2024-09-01 → 2025-08-01 3. primary completion date: 2024-09-01 → 2025-07-23 4. enrollment: 70 → 8 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07286149: completion date: 2037-05-06 → 2032-04-13.

Clinical trial NCT07061288: enrollment: 48 → 116 participants.

Clinical trial NCT06471829: completion date: 2027-11-30 → 2027-10-31.

Clinical trial NCT07583563 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-05

Clinical trial NCT07425054: start date: 2026-03-01 → 2026-06-01.

Clinical trial NCT07602283 updates: 1. start date: 2026-06-01 → 2026-06-09 2. collaborators removed: Yale University School of Medicine, Department of Psychiatry